Performance of ARWR Arrowhead | -31.4% in 12m
Compare ARWR with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Arrowhead with its related Sector/Index XBI
Performance Duell ARWR vs XBI
| TimeFrame | ARWR | XBI |
|---|---|---|
| 1 Week | -12.7% | 0.39% |
| 1 Month | -8.72% | 3.23% |
| 3 Months | -15.0% | 7.10% |
| 6 Months | -28.8% | 2.26% |
| 12 Months | -31.4% | 26.63% |
| YTD | -32.5% | 9.75% |
| Rel. Perf. 1m | -1.34 | |
| Rel. Perf. 3m | -2.15 | |
| Rel. Perf. 6m | -3.18 | |
| Rel. Perf. 12m | -3.18 | |
| Spearman 1m | -0.27 | 0.03 |
| Spearman 3m | -0.55 | 0.63 |
Is Arrowhead a good stock to buy?
Probably not. Based on ValueRay Analyses, Arrowhead (NASDAQ:ARWR) is currently (September 2024)
not a good stock to buy. It has a ValueRay Growth Rating of -36.40 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARWR as of September 2024 is 17.80. This means that ARWR is currently overvalued and has a potential downside of -15% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of ARWR as of September 2024 is 17.80. This means that ARWR is currently overvalued and has a potential downside of -15% (Sold with Premium).
Is ARWR a buy, sell or hold?
- Strong Buy: 7
- Buy: 3
- Hold: 5
- Sell: 0
- Strong Sell: 0
Values above 0%: ARWR is performing better - Values below 0%: ARWR is underperforming
Compare ARWR with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -13.31% | -12.69% | -37.91% | -56.26% |
| US NASDAQ 100 | QQQ | -14.42% | -12.54% | -36.23% | -56.50% |
| US Dow Jones Industrial 30 | DIA | -12.40% | -12.74% | -34.99% | -50.45% |
| German DAX 40 | DBXD | -11.32% | -12.12% | -31.63% | -47.01% |
| UK FTSE 100 | ISFU | -10.94% | -10.93% | -39.54% | -48.05% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -10.94% | -5.76% | -19.70% | -20.15% |
| Hongkong Hang Seng | HSI | -12.24% | -10.86% | -26.36% | -25.07% |
| Japan Nikkei 225 | EXX7 | -11.62% | -12.47% | -24.28% | -40.56% |
| India NIFTY 50 | INDA | -11.94% | -11.33% | -38.85% | -57.67% |
| Brasil Bovespa | EWZ | -11.40% | -7.94% | -22.69% | -27.83% |
ARWR Arrowhead vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -11.68% | -8.53% | -35.67% | -56.15% |
| Consumer Discretionary | XLY | -14.85% | -17.59% | -34.37% | -40.45% |
| Consumer Staples | XLP | -11.90% | -13.90% | -40.03% | -48.82% |
| Energy | XLE | -8.77% | -2.60% | -25.00% | -24.81% |
| Financial | XLF | -10.11% | -13.70% | -38.44% | -60.09% |
| Health Care | XLV | -11.82% | -12.65% | -35.68% | -49.86% |
| Industrial | XLI | -12.36% | -12.46% | -34.89% | -54.85% |
| Materials | XLB | -11.87% | -11.95% | -30.35% | -43.82% |
| Real Estate | XLRE | -15.10% | -16.54% | -42.80% | -57.14% |
| Technology | XLK | -16.43% | -13.65% | -34.34% | -58.73% |
| Utilities | XLU | -13.27% | -13.52% | -51.37% | -53.98% |
| Aerospace & Defense | XAR | -11.46% | -11.16% | -36.98% | -60.66% |
| Biotech | XBI | -13.07% | -11.95% | -31.04% | -58.06% |
| Homebuilder | XHB | -12.93% | -14.41% | -38.19% | -72.88% |
| Retail | XRT | -10.18% | -8.10% | -25.49% | -47.74% |
Does Arrowhead outperform its market, is ARWR a Sector Leader?
No, over the last 12 months Arrowhead (ARWR) made -31.43%, while its related Sector, the SPDR S&P Biotech (XBI) made 26.63%.
Over the last 3 months ARWR made -15.02%, while XBI made 7.10%.
No, over the last 12 months Arrowhead (ARWR) made -31.43%, while its related Sector, the SPDR S&P Biotech (XBI) made 26.63%.
Over the last 3 months ARWR made -15.02%, while XBI made 7.10%.
| Period | ARWR | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -8.72% | 3.23% | 3.97% |
| 3 Months | -15.02% | 7.10% | 3.59% |
| 12 Months | -31.43% | 26.63% | 24.83% |